Joseph DiMasi : Citation Profile


Are you Joseph DiMasi?

6

H index

5

i10 index

534

Citations

RESEARCH PRODUCTION:

11

Articles

4

Papers

RESEARCH ACTIVITY:

   28 years (1988 - 2016). See details.
   Cites by year: 19
   Journals where Joseph DiMasi has often published
   Relations with other researchers
   Recent citing documents: 54.    Total self citations: 5 (0.93 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pdi386
   Updated: 2021-10-16    RAS profile: 2016-05-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Joseph DiMasi.

Is cited by:

Siebert, Ralph (11)

Pammolli, Fabio (8)

Banerjee, Tannista (8)

Magazzini, Laura (8)

La Croix, Sumner (8)

Boldrin, Michele (7)

Pertile, Paolo (7)

Levine, David (7)

Philipson, Tomas (6)

Billette de Villemeur, Etienne (6)

Versaevel, Bruno (6)

Cites to:

Lichtenberg, Frank (2)

Fama, Eugene (1)

Harvey, Campbell (1)

Cockburn, Iain (1)

Philipson, Tomas (1)

Olson, Mary (1)

French, Kenneth (1)

Main data


Where Joseph DiMasi has published?


Journals with more than one article published# docs
Journal of Health Economics5
Managerial and Decision Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Duke University, Department of Economics2

Recent works citing Joseph DiMasi (2021 and 2020)


YearTitle of citing document
2021.

Full description at Econpapers || Download paper

2020Optimal Experimental Design for Staggered Rollouts. (2019). Imbens, Guido ; Bayati, Mohsen ; Athey, Susan ; Xiong, Ruoxuan. In: Papers. RePEc:arx:papers:1911.03764.

Full description at Econpapers || Download paper

2020Economic Activity and the Value of Medical Innovation during a Pandemic. (2020). Mulligan, Casey B. In: Working Papers. RePEc:bfi:wpaper:2020-48.

Full description at Econpapers || Download paper

2020Enhancing the Financial Returns of R&D Investments through Operations Management. (2020). , Hugo ; Daphne, L M ; T. C. E. Cheng, . In: Production and Operations Management. RePEc:bla:popmgt:v:29:y:2020:i:7:p:1658-1678.

Full description at Econpapers || Download paper

2020R&D and Innovation: Evidence from Patent Data. (2020). Takahashi, Koji ; Oh, Yusuke. In: Bank of Japan Working Paper Series. RePEc:boj:bojwps:wp20e07.

Full description at Econpapers || Download paper

2020Dynamic Mergers Effects on R&D Investments and Drug Development across Research Phases in the Pharmaceutical Industry. (2020). Tian, Zhili ; Siebert, Ralph. In: CESifo Working Paper Series. RePEc:ces:ceswps:_8303.

Full description at Econpapers || Download paper

2020Dynamic Effects of Licensing and Knowledge Transfer across Research Stages: Evidence from the Pharmaceutical Industry. (2020). Siebert, Ralph ; Tian, Zhili. In: CESifo Working Paper Series. RePEc:ces:ceswps:_8311.

Full description at Econpapers || Download paper

2021Centrality analysis in a drug network and its application to drug repositioning. (2021). Ratnavelu, Kurunathan ; Kwa, Kiam Heong ; Keng, Ying Ying. In: Applied Mathematics and Computation. RePEc:eee:apmaco:v:395:y:2021:i:c:s0096300320308237.

Full description at Econpapers || Download paper

2020Volatility costs of R&D. (2020). Aysun, Uluc. In: European Economic Review. RePEc:eee:eecrev:v:122:y:2020:i:c:s0014292119302260.

Full description at Econpapers || Download paper

2020Role of rent-seeking or technological progress in maintaining the monopoly power of energy enterprises: An empirical analysis based on micro-data from China. (2020). Wang, Faming ; Li, Mengjie ; Du, Weijian. In: Energy. RePEc:eee:energy:v:202:y:2020:i:c:s0360544220308707.

Full description at Econpapers || Download paper

2020An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?. (2020). van Overbeeke, Eline ; Pinto, Cathy Anne ; Cleemput, Irina ; Stephen, Watt ; Mauer, Jonathan ; Bywall, Karin Scholin ; Whichello, Chiara ; Veldwijk, Jorien ; Hermann, Richard ; de Bekker-Grob, Esther W ; Huys, Isabelle. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:12:p:1325-1332.

Full description at Econpapers || Download paper

2020Reaching for mediocrity: Competition and stagnation in pharmaceutical innovation. (2020). Sukhatme, Neel U ; Le, Son. In: International Review of Law and Economics. RePEc:eee:irlaec:v:64:y:2020:i:c:s0144818820301472.

Full description at Econpapers || Download paper

2020Perceived project transition support and employees assessments of entrepreneurial project performance. (2020). Patzelt, Holger ; Shepherd, Dean A ; Wolfe, Marcus T ; Behrens, Judith. In: Journal of Business Venturing. RePEc:eee:jbvent:v:35:y:2020:i:1:s0883902617304020.

Full description at Econpapers || Download paper

2020Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D. (2020). Sanzenbacher, Geoffrey ; Wettstein, Gal. In: Journal of Health Economics. RePEc:eee:jhecon:v:72:y:2020:i:c:s0167629619305703.

Full description at Econpapers || Download paper

2021Strategic green technology innovation in a two-stage alliance: Vertical collaboration or co-development?. (2021). Lan, Yanfei ; Yu, Xinning ; Zhao, Ruiqing. In: Omega. RePEc:eee:jomega:v:98:y:2021:i:c:s0305048318312040.

Full description at Econpapers || Download paper

2021COVID-19 vaccine rollout—scale and speed carry different implications for corruption. (2021). Nelson, Michael ; Goel, Rajeev. In: Journal of Policy Modeling. RePEc:eee:jpolmo:v:43:y:2021:i:3:p:503-520.

Full description at Econpapers || Download paper

2021The fall of the innovation empire and its possible rise through open science. (2021). Gold, Richard E. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:5:s0048733321000305.

Full description at Econpapers || Download paper

2020Antecedents and relative performance of sourcing choices for new product development projects. (2020). Contractor, Farok ; Bruyaka, Olga ; Thakur-Wernz, Pooja. In: Technovation. RePEc:eee:techno:v:90-91:y:2020:i::s0166497217306041.

Full description at Econpapers || Download paper

2020DIY Laboratories and business innovation ecosystems: The case of pharmaceutical industry. (2020). He, Qile ; Wu, Qiang. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:161:y:2020:i:c:s0040162520311628.

Full description at Econpapers || Download paper

2020Impact of Research and Development Strategy on Sustainable Growth in Multinational Pharmaceutical Companies. (2020). Kodama, Kota ; Sengoku, Shintaro ; Lim, Yeongjoo ; Makino, Tomohiro ; Teramae, Fumio. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:13:p:5358-:d:379480.

Full description at Econpapers || Download paper

2020Trends of Business-to-Business Transactions to Develop Innovative Cancer Drugs. (2020). Kodama, Kota ; Sengoku, Shintaro ; Lim, Yeongjoo ; Makino, Tomohiro ; Djurian, Arisa. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:14:p:5535-:d:382188.

Full description at Econpapers || Download paper

2020Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth. (2020). Sengoku, Shintaro ; Makino, Tomohiro ; Teramae, Fumio ; Kodama, Kota ; Natori, Takashi ; Lim, Yeongjoo. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:21:p:8938-:d:435743.

Full description at Econpapers || Download paper

2021Determinants of Internationalization as Levers for Sustainability: A Study of the Portuguese Pharmaceutical Sector. (2021). Martinho, Domingos ; Ascenso, Raquel ; Frade, Rui ; Vieira, Jorge. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:17:p:9792-:d:626308.

Full description at Econpapers || Download paper

2021Communication for Open Innovation in Japanese Drug Discovery Ventures. (2021). Tomita, Kenji. In: Journal of Management Sciences. RePEc:gei:journl:v:8:y:2021:i:1:p:36-49.

Full description at Econpapers || Download paper

2020An Approximation Approach for Response-Adaptive Clinical Trial Design. (2020). Birge, John R ; Ahuja, Vishal. In: INFORMS Journal on Computing. RePEc:inm:orijoc:v:32:y:4:i:2020:p:877-894.

Full description at Econpapers || Download paper

2020Strategic Research and Development Investment Decisions in the Pharmaceutical Industry. (2020). Rao, Anita. In: Marketing Science. RePEc:inm:ormksc:v:39:y:2020:i:3:p:564-586.

Full description at Econpapers || Download paper

2021Rushed Innovation: Evidence from Drug Licensing. (2021). Hermosilla, Manuel. In: Management Science. RePEc:inm:ormnsc:v:67:y:2021:i:1:p:257-278.

Full description at Econpapers || Download paper

2020A Review of the Healthcare-Management (Modeling) Literature Published in Manufacturing & Service Operations Management. (2020). Savva, Nicos ; Keskinocak, Pinar. In: Manufacturing & Service Operations Management. RePEc:inm:ormsom:v:22:y:2020:i:1:p:59-72.

Full description at Econpapers || Download paper

2021Inducing Compliance with Postmarket Studies for Drugs Under FDA’s Accelerated Approval Pathway. (2021). Petruzzi, Nicholas C ; Zhao, Hui ; Xu, Liang. In: Manufacturing & Service Operations Management. RePEc:inm:ormsom:v:23:y:2021:i:1:p:170-190.

Full description at Econpapers || Download paper

2020Competition, Technology Licensing-in, and Innovation. (2020). Tasselli, Stefano ; Klueter, Thomas Maximilian ; Moreira, Solon. In: Organization Science. RePEc:inm:ororsc:v:31:y:2020:i:4:p:1012-1036.

Full description at Econpapers || Download paper

2021Do companies in the pharmaceutical supply chain earn excess returns?. (2021). Zhong, Kimberly ; Mulligan, Karen ; Sood, Neeraj. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:21:y:2021:i:1:d:10.1007_s10754-020-09291-1.

Full description at Econpapers || Download paper

2021Microgravity protein crystallization for drug development: a bold example of public sector entrepreneurship. (2021). Vonortas, Nicholas S ; Scott, Troy J. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:46:y:2021:i:5:d:10.1007_s10961-019-09743-y.

Full description at Econpapers || Download paper

2020Method-of-Use Patents, Appropriability, and Antitrust Policy. (2020). Blair, Roger D ; Walsh, Anita N. In: Review of Industrial Organization. RePEc:kap:revind:v:56:y:2020:i:4:d:10.1007_s11151-020-09753-3.

Full description at Econpapers || Download paper

2021Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions. (2021). Bennato, Anna Rita ; Mariuzzo, Franco. In: Small Business Economics. RePEc:kap:sbusec:v:57:y:2021:i:1:d:10.1007_s11187-019-00307-w.

Full description at Econpapers || Download paper

2020High prices of new drugs: we are ready to do whatever it takes. (2020). Capri, Stefano. In: LIUC Papers in Economics. RePEc:liu:liucec:2020-8.

Full description at Econpapers || Download paper

2020Economic Activity and the Value of Medical Innovation during a Pandemic. (2020). Mulligan, Casey. In: NBER Working Papers. RePEc:nbr:nberwo:27060.

Full description at Econpapers || Download paper

2020Insurance Design and Pharmaceutical Innovation. (2020). Agha, Leila ; Li, Danielle ; Kim, Soomi. In: NBER Working Papers. RePEc:nbr:nberwo:27563.

Full description at Econpapers || Download paper

2020Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination. (2020). Wasserman, Melissa F ; Frakes, Michael D. In: NBER Working Papers. RePEc:nbr:nberwo:27579.

Full description at Econpapers || Download paper

2020Regionalization of R&D activities: (Dis)economies of interdependence and inventive performance. (2020). Roy, Raja ; Lampert, Curba Morris ; Kim, Minyoung. In: Journal of International Business Studies. RePEc:pal:jintbs:v:51:y:2020:i:7:d:10.1057_s41267-020-00314-0.

Full description at Econpapers || Download paper

2020Game theoretic analysis of persons, the pharmaceutical industry, and donors in disease contraction and recovery. (2020). Hausken, Kjell ; Ncube, Mthuli. In: Palgrave Communications. RePEc:pal:palcom:v:7:y:2020:i:1:d:10.1057_s41599-020-00626-4.

Full description at Econpapers || Download paper

2021Comparing long-term value creation after biotech and non-biotech IPOs, 1997–2016. (2021). Ledley, Fred D ; Fitzgerald, Liam ; Holden, Jeremy ; de Boer, Skyler ; McNamee, Laura M ; Cleary, Ekaterina Galkina. In: PLOS ONE. RePEc:plo:pone00:0243813.

Full description at Econpapers || Download paper

2020Why is productivity slowing down?. (2020). Lafond, François ; Winkler, Julian ; Koutroumpis, Pantelis ; Goldin, Ian. In: MPRA Paper. RePEc:pra:mprapa:99172.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020A novel valuation model for medical intervention development based on progressive dynamic changes that integrates Health Technology Assessment outcomes with early-stage innovation and indication-speci. (2020). Lebmeier, Maximilian ; Dando, Jonathan. In: Journal of Innovation and Entrepreneurship. RePEc:spr:joiaen:v:9:y:2020:i:1:d:10.1186_s13731-019-0111-1.

Full description at Econpapers || Download paper

2020Exploring scientific publications by firms: what are the roles of academic and corporate partners for publications in high reputation or high impact journals?. (2020). Rake, Bastian ; McKelvey, Maureen. In: Scientometrics. RePEc:spr:scient:v:122:y:2020:i:3:d:10.1007_s11192-020-03344-5.

Full description at Econpapers || Download paper

2020Innovation in pharmaceutical R&D: mapping the research landscape. (2020). Sijde, Peter ; Kenneth, Angelo ; Muijlwijk-Koezen, Jacqueline. In: Scientometrics. RePEc:spr:scient:v:125:y:2020:i:3:d:10.1007_s11192-020-03707-y.

Full description at Econpapers || Download paper

2020Impact of innovative activity of organizations on the development of pharmaceutical industry: a case study. (2020). Islamova, Guzal Ilgizovna ; Glukhova, Marina Ivanovna ; Fedorova, Yulia Vyacheslavovna ; Borscheva, Natalia Leonidovna. In: Entrepreneurship and Sustainability Issues. RePEc:ssi:jouesi:v:7:y:2020:i:4:p:3001-3015.

Full description at Econpapers || Download paper

2020Does Medicare Reimbursement Drive Up Drug Launch Prices?. (2020). Ridley, David ; Lee, Chung-Ying. In: The Review of Economics and Statistics. RePEc:tpr:restat:v:102:y:2020:i:5:p:980-993.

Full description at Econpapers || Download paper

2020Incentivizing New Veterinary Pharmaceutical Products to Combat Antibiotic Resistance. (2020). Clancy, Matt ; Sneeringer, Stacy. In: Applied Economic Perspectives and Policy. RePEc:wly:apecpp:v:42:y:2020:i:4:p:653-673.

Full description at Econpapers || Download paper

2020Patient income and health innovation. (2020). Hollis, Aidan ; Moradpour, Javad. In: Health Economics. RePEc:wly:hlthec:v:29:y:2020:i:12:p:1795-1803.

Full description at Econpapers || Download paper

2020Innovation, aging, and health care: Unraveling “silver” from “red” herrings?. (2020). LEVAGGI, ROSELLA ; Costa-Font, Joan ; Costafont, Joan. In: Health Economics. RePEc:wly:hlthec:v:29:y:2020:i:s1:p:3-7.

Full description at Econpapers || Download paper

2021Regulatory review time and pharmaceutical research and development. (2021). Bailey, James ; Chorniy, Anna ; Maloney, Michael ; Civan, Abdulkadir . In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:113-128.

Full description at Econpapers || Download paper

2021Do pharmaceutical prices rise anticipating branded competition?. (2021). Basu, Anirban ; Ellyson, Alice M. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:1070-1081.

Full description at Econpapers || Download paper

Works by Joseph DiMasi:


YearTitleTypeCited
2003Returns on R&D for 1990s New Drug Introductions In: Levine's Working Paper Archive.
[Full Text][Citation analysis]
paper1
2002Returns on R&D for 1990s New Drug Introductions.(2002) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 1
paper
2003Returns on R&D for 1990s New Drug Introductions: Charts In: Levine's Working Paper Archive.
[Full Text][Citation analysis]
paper0
1995R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry In: Working Papers.
[Citation analysis]
paper13
1995R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry.(1995) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 13
article
1991Cost of innovation in the pharmaceutical industry In: Journal of Health Economics.
[Full Text][Citation analysis]
article109
2003The price of innovation: new estimates of drug development costs In: Journal of Health Economics.
[Full Text][Citation analysis]
article293
2005Extraordinary claims require extraordinary evidence In: Journal of Health Economics.
[Full Text][Citation analysis]
article5
2005Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder In: Journal of Health Economics.
[Full Text][Citation analysis]
article4
2016Innovation in the pharmaceutical industry: New estimates of R&D costs In: Journal of Health Economics.
[Full Text][Citation analysis]
article80
1988Property tax classification and welfare in urban areas: A general equilibrium computational approach In: Journal of Urban Economics.
[Full Text][Citation analysis]
article0
2005The economics of follow-on drug research and development: Trends in entry rates and the timing of development — The authors’ reply In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2010Drug development costs when financial risk is measured using the Fama–French three‐factor model In: Health Economics.
[Full Text][Citation analysis]
article7
2007Commentary In: Managerial and Decision Economics.
[Full Text][Citation analysis]
article0
2007The cost of biopharmaceutical R&D: is biotech different? In: Managerial and Decision Economics.
[Full Text][Citation analysis]
article21

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 2 2021. Contact: CitEc Team